China Universal Asset Management Company’s Spyre Therapeutics SYRE Stock Holding History

China Universal Asset Management Company’s Portfolio SYRE Stock Details SYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$181K	Buy
2025 Q1	$195K	Sell
2024 Q4	$290K	Buy
2022 Q4	–	Sell
2022 Q3	$0	Buy